Michael Rawlins

Business address
C/O Intra Cellular Therapies, Inc., 3960 Broadway, New York, NY, 10032
Top holdings (ownership)
ITCI
Get insider transactions for this reporting owner
Michael Rawlins has filed 5 SEC EDGAR filings since 09 Sep 2013

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing FORM 4 SUBMISSION 13 Jun 2022 09 Jun 2022 001-36274
4 Open Document Open Filing FORM 4 SUBMISSION 22 Jun 2021 21 Jun 2021 001-36274
3 Open Document Open Filing FORM 3 SUBMISSION 22 Jun 2021 21 Jun 2021 001-36274
4 Open Document Open Filing FORM 4 - MICHAEL RAWLINS, M.D., FRCP, FMEDSCI 02 Jul 2014 30 Jun 2014 001-36274